FDA — authorised 19 October 2016
- Marketing authorisation holder: ELI LILLY AND CO
- Status: approved
🇺🇸 Lartruvo in United States
FDA authorised Lartruvo on 19 October 2016
Marketing authorisations
FDA — authorised 19 October 2016
- Application: BLA761038
- Marketing authorisation holder: ELI LILLY AND CO
- Local brand name: LARTRUVO
- Indication: INJECTABLE — INJECTION
- Status: approved
Lartruvo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Lartruvo approved in United States?
Yes. FDA authorised it on 19 October 2016; FDA authorised it on 19 October 2016.
Who is the marketing authorisation holder for Lartruvo in United States?
ELI LILLY AND CO holds the US marketing authorisation.